Contraception
RSSArticles
-
Intrauterine Device String Checks: Are They Necessary?
Two-thirds of women complied with the recommendation for a six-week follow-up visit after intrauterine device (IUD) insertion. Among these women, 19.8% had their IUD removed in the first year compared to 12.6% among women who did not attend the follow-up visit. The majority of removals occurred outside the six-week follow-up period.
-
Breast Cancer and Hormonal Contraception: New Information or Sensationalism?
Highly publicized results from the Danish database demonstrate an increase in the risk of breast cancer associated with current use of hormonal contraception. Consistent with prior research, the risk is small, confined to current users, and disappears following discontinuation.
-
Does Postpartum Use of Hormonal Contraception Increase Risk of Depression?
An analysis of a large insurance database showed no consistent effect between postpartum initiation of hormonal contraception and the subsequent diagnosis of depression.
-
The LNG IUS and Stress Reactivity: A Mechanism for Mood Effects or False Signal?
Users of the levonorgestrel (LNG) intrauterine system showed an exaggerated response to stress compared to women using a combined LNG pill or those with natural cycles.
-
Do Antibiotics Reduce Hormonal Contraceptive Effectiveness?
This is a systematic review of studies evaluating the effect of concomitant non-rifamycin antibiotic use on hormonal contraceptive effectiveness. Although data are limited, there is no evidence to support the existence of drug interactions.
-
Reproductive Rights in 2017: Follow-up and Call for Advocacy
The Trump administration has made good on a number of promises to roll back reproductive rights. As clinicians, we need to fight back to ensure access for our patients to essential services. This article seeks to document where we stand as of summer 2017, and present opportunities for engagement.
-
Oral Contraceptives and Quality of Life
In this three-month randomized, double-blind trial comparing oral contraceptives to placebo, the authors found a small decrease in general well-being scores but no effect on depressive symptoms. The short time period and small effect size introduce doubt into the validity of these findings.
-
Contraception: More Effective Than Ever?
A new analysis from the National Survey of Family Growth demonstrates a decrease from 12% in 2002 to 10% in 2006-2010 in the overall rate of failure among women using reversible methods of contraception.
-
Contraception, Migraines, and Stroke
In this case-control study, women with migraines with aura using combined hormonal contraception had six times the odds of experiencing ischemic stroke compared to women without migraines not using combined hormonal contraception. Use of combined hormonal contraception among women with migraines without aura was not associated with an increased risk of stroke over baseline.
-
Reproductive Rights in 2017: Standing Strong for Women
The evidence strongly suggests that comprehensive family planning services provided under the Affordable Care Act that include subsidized coverage for highly effective long-acting reversible contraception have contributed to a decrease in the rate of unintended pregnancy and a sharp decline in abortions. As women’s healthcare providers, we should be leaders in standing up to policy changes that will endanger women and threaten our most vulnerable citizens.